A raised androgen level means the androgen signal reaching your tissues is stronger than it usually is, not that a male hormone has appeared where it does not belong. Androgens are normal and necessary in women. The ovaries and the adrenal glands both produce them, and they contribute to libido, bone density, muscle, mood and the behaviour of skin and hair follicles.
The androgens that matter in this conversation are testosterone, androstenedione, DHEA and DHEA sulfate (DHEA-S). DHEA-S comes almost entirely from the adrenal glands, which is why it is useful for working out where extra androgen is coming from. Testosterone Total measures everything circulating, bound and unbound together. Most of that total is stuck to sex hormone binding globulin (SHBG) and to albumin, and only the small unbound fraction can enter cells and act on a receptor.
There is a second step that explains a lot of the confusion. Skin, including hair follicles and oil glands, converts testosterone locally into a more potent androgen, so what the blood shows and what the skin experiences are not the same measurement. For this reason clinicians separate clinical hyperandrogenism, meaning the visible features, from biochemical hyperandrogenism, meaning the lab numbers, and the two do not always line up in the same person 1.
Practically, a value above a standard range is an observation. It may reflect ovarian androgen production, adrenal production, a low binding protein, or the limits of the assay used. It is worth discussing with a clinician rather than acting on alone. Typical reference ranges and optimal targets for the marker itself live on the Testosterone Total guide, so this page stays with the symptoms, the causes and the workup.
The classic cluster is unwanted coarse hair in a male distribution, acne that persists or returns in adulthood, thinning hair on the scalp and cycles that are long, unpredictable or absent. Any one of these alone can have other explanations; together they form the pattern a clinician looks for.
Hair in androgen-dependent areas. Hirsutism means terminal hair, the coarse pigmented kind, growing in areas where androgens drive follicle growth, such as the upper lip, chin, chest, upper abdomen, lower back and inner thighs. It is different from hypertrichosis, which is generalised fine hair growth that is not androgen driven, and clinicians grade the distribution using a standardised visual scale rather than counting individual hairs 1. Normal hair density varies considerably between individuals and between populations, so the same score carries different weight in different people 1.
Acne that behaves differently. Androgen-related acne tends to be inflammatory, to sit along the jawline, chin, neck, chest or back, and to persist well past adolescence or appear for the first time in adulthood.
Scalp thinning. Female pattern hair loss shows up as diffuse thinning over the crown and a widening part, usually with the frontal hairline preserved, and it is a recognised presentation that prompts an androgen evaluation in the right clinical context 3.
Cycle changes. Cycles consistently longer than about 35 days, very few cycles per year, or absent periods point to ovulatory dysfunction, which is one of the core diagnostic features of polycystic ovary syndrome 2.
Skin changes that hint at metabolism. Darkened velvety skin at the neck, armpits or groin, and multiple skin tags, are features described in polycystic ovary syndrome alongside insulin resistance 4.
One more thing explains why two women with nearly identical lab values can look completely different. Follicle sensitivity and the amount of local conversion in skin vary from person to person, so a modest rise in circulating androgen produces obvious changes in one woman and almost nothing in another. That is also why visible features can appear while blood values stay inside the standard range.
Polycystic ovary syndrome (PCOS) accounts for the large majority of cases, and it is the most common endocrine disorder in women of reproductive age 2. If you only remember one cause, remember this one.
PCOS is defined by international criteria that require two of three features, namely ovulatory dysfunction, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound, with other causes of androgen excess excluded first 5. Because two of three are enough, the condition presents in several different phenotypes, and two women can both meet criteria while having very different symptoms and very different metabolic pictures 4.
The hormonal pattern behind it involves more than the ovary. Luteinising hormone pulse frequency is typically increased relative to follicle stimulating hormone, which pushes ovarian theca cells toward androgen output, and SHBG tends to run low so that a larger share of circulating testosterone is free and active 6. Low SHBG is associated with a higher free androgen fraction in polycystic ovary syndrome, which is why a woman can have a mid-range total testosterone and still show clear skin and hair features 6.
Metabolism is woven through the picture. Research suggests that, in polycystic ovary syndrome, insulin resistance and the resulting higher insulin levels contribute to increased ovarian androgen production and to lower SHBG 2. That creates a self-reinforcing loop, which is one reason metabolic markers belong in the same workup as hormone markers.
None of this means a single raised result confirms PCOS. The diagnosis is clinical, it requires a cycle history and often imaging, and it is made by a clinician after other causes have been considered 5.
Yes, and the giveaway is usually a DHEA-S that is disproportionately high compared with testosterone, because DHEA-S is produced almost exclusively by the adrenal cortex.
The adrenal cause worth knowing about is non-classic congenital adrenal hyperplasia, most often caused by partial 21-hydroxylase enzyme deficiency. The enzyme block is incomplete, so cortisol production is relatively preserved, but steroid precursors accumulate upstream and are diverted into androgen production. The non-classic form typically becomes apparent in adolescence or adulthood rather than at birth, and it can present with hirsutism, acne and irregular cycles that look essentially identical to PCOS 7.
Because the two overlap so closely, screening matters. An early morning 17-hydroxyprogesterone drawn in the follicular phase is the standard screening step, with a stimulation test used when the screening value sits in an indeterminate zone 7. The hirsutism guideline also supports screening for this condition in women with hirsutism who have suggestive features, including a family history or ancestry from higher-prevalence populations 1.
Other adrenal conditions can raise androgens too, including states of cortisol excess, which usually bring their own distinctive features such as central weight gain, skin fragility, purple stretch marks, muscle weakness and blood pressure changes. These are far less common, and they are identified through a targeted evaluation rather than a routine panel.
The practical point is that identifying the gland changes the entire plan of care. An ovarian pattern and an adrenal pattern can produce the same complaint in the mirror and call for a different evaluation path, which is why DHEA-S and 17-hydroxyprogesterone are standard parts of the workup rather than optional extras.
Speed and severity. Androgen excess that develops gradually over years usually has a common cause. Androgen excess that appears over weeks to months and keeps progressing is the pattern that calls for prompt attention.
The specific features clinicians watch for are collectively called virilisation. They include deepening of the voice, enlargement of the clitoris, male pattern recession at the temples, a noticeable increase in muscle bulk, loss of breast fullness and rapid, severe hirsutism. These features, especially when they develop quickly, raise concern for an androgen-secreting tumour of the ovary or adrenal gland, which is uncommon but requires evaluation without delay 1. Markedly elevated total testosterone or DHEA-S in that setting typically leads to imaging of the ovaries and adrenal glands 1.
Nothing here means that a single high value is a crisis. Most raised androgen results in women are not tumour-related. But the combination of rapid onset, progression and virilising features changes the urgency of the conversation, and it is worth discussing with a clinician promptly rather than waiting for the next routine appointment.
It is equally important not to go the other way. A result outside the standard range should never be ignored or explained away without an evaluation, even when symptoms are mild or absent.
The core set is total testosterone, free testosterone, SHBG, DHEA-S and early morning 17-hydroxyprogesterone, read together with a careful cycle and symptom history.
Total testosterone. This is the starting point, but the assay matters more than most people realise. Many routine immunoassays were optimised for the much higher concentrations seen in men and perform poorly at the low concentrations typical in women, so mass spectrometry based methods or extraction and chromatography methods are preferred for accuracy in this population 1.
Free testosterone. Since only the unbound fraction acts on tissue, free testosterone often explains symptoms better than total. The reliable approaches are equilibrium dialysis or calculation from total testosterone and SHBG, while direct analogue free testosterone immunoassays are regarded as unreliable 1.
SHBG. It is not an afterthought. SHBG sets the ratio between total and free, so the same total value means two different things at a low SHBG and a high one.
DHEA-S. This separates adrenal from ovarian sources, as described above.
17-hydroxyprogesterone. Drawn in the early morning and in the follicular phase, this screens for non-classic congenital adrenal hyperplasia 7.
Around those numbers sits the part no panel can replace. A clinician will ask when symptoms started and how fast they progressed, how long cycles run and how many occur per year, what medications and supplements are in use, what the family history looks like, and what the skin and hair pattern shows on examination. Lab values narrow the possibilities; the history and examination decide which possibility fits.
SHBG is the carrier protein that holds most circulating testosterone in a bound, inactive state, so when SHBG falls, a larger proportion of the same total becomes free and biologically active.
This is the single most common reason a woman is told her testosterone is normal while her skin and hair say otherwise. If SHBG is low, total testosterone can sit comfortably within a standard range while free testosterone is elevated and tissue exposure is genuinely high. Conditions of insulin resistance and higher body weight are associated with lower SHBG, which is part of why this pattern shows up so often in polycystic ovary syndrome 6.
The reverse happens too. Anything that raises SHBG pulls more testosterone into the bound pool, which can push total testosterone up while free testosterone stays unremarkable. Oestrogen-containing hormonal contraception raises SHBG and suppresses ovarian androgen production, which is one reason androgen testing is usually interpreted with contraceptive use explicitly in mind 1.
The takeaway is procedural rather than dramatic. Ordering total testosterone without SHBG gives you half a sentence. Ordering both, and either calculating free testosterone or measuring it by a reliable method, gives a clinician something interpretable 1.
Morning, and in the early follicular phase of the cycle when cycles are regular enough to time, roughly days 2 to 5 counting from the first day of bleeding.
Timing matters for two separate reasons. Androgens follow a daily rhythm and run higher in the morning, so an afternoon draw can understate the picture. And 17-hydroxyprogesterone rises naturally after ovulation, which means a luteal phase sample can produce a value that looks abnormal when it is simply mistimed, so screening is done on an early morning follicular sample 7.
When cycles are absent or completely unpredictable, waiting for a perfect window is not practical. In that situation testing proceeds on any convenient morning and the result is interpreted with the irregularity in mind, which is itself part of the clinical information.
Several things can move or muddy a result. Hormonal contraception changes both SHBG and ovarian androgen output, so a clinician needs to know exactly what is being taken and when it was last used 1. Assay choice introduces real variability at female concentrations, which is why comparing a value from one laboratory to a value from another is not a like for like comparison 1. And biological variation means borderline values are frequently worth repeating before anyone draws conclusions from them.
One borderline number is a prompt to look more carefully. It is not a verdict.
A well-built panel surrounds the androgens with the markers that explain them, rather than testing testosterone in isolation.
The usual companions are luteinising hormone and follicle stimulating hormone, which describe the signal coming from the pituitary, prolactin and thyroid stimulating hormone, which cover other endocrine causes of cycle disruption, and anti-Mullerian hormone, which reflects ovarian follicle numbers. Alongside those sit the metabolic markers, including fasting glucose, fasting insulin or HbA1c, and a lipid panel, because metabolic features are a recognised part of the polycystic ovary syndrome picture rather than a separate issue 4. Ferritin and a full blood count are often added when scalp thinning is a main complaint, since iron status and other systemic factors contribute to hair shedding independent of androgens 3.
This is also where a broad, repeated panel earns its place. FitScript's membership includes 150+ biomarkers tested per year, with results interpreted by Atlas, its AI health advisor, so hormone, metabolic and nutrient markers can be read together and tracked across time rather than judged from one snapshot.
What that breadth buys you is context. A single androgen value answers almost nothing on its own. The same value alongside SHBG, fasting insulin, DHEA-S and a cycle history usually points clearly toward the next question worth asking.
By matching the shape of the story to the shape of the labs, in that order.
The history sets the frame. Gradual onset beginning around adolescence, long or skipped cycles and a family history of similar features leans toward polycystic ovary syndrome, which is diagnosed using established criteria only after other causes have been excluded 5. Onset in adolescence or early adulthood with a disproportionately raised DHEA-S or an abnormal morning 17-hydroxyprogesterone redirects attention to the adrenal glands 7. Rapid onset with virilising features moves imaging to the front of the queue 1.
The examination adds what blood cannot. Where the coarse hair grows, how the scalp is thinning, whether skin changes suggesting insulin resistance are present, and whether any virilising features exist all narrow the list 1.
Then the labs are read as a set. The useful question is not simply whether testosterone is high, but whether the elevation is mild or marked, whether it is total or free that is raised, whether SHBG explains the gap, and whether the adrenal markers move in parallel.
The honest summary is that a lot of cases are not clean. Features overlap, phenotypes vary and some women meet criteria with one feature barely present 4. That is exactly why the conclusion belongs to a clinician who can see the whole picture, not to a single flagged line on a report.
Care usually runs on two tracks at once, namely methods that remove or destroy the hair directly, and medication that reduces androgen effect at the follicle, which a licensed provider decides on after an evaluation.
Direct methods include photoepilation with laser or intense pulsed light and electrolysis, which are recognised options for localised unwanted hair and are often used alongside medication rather than instead of it 1. Shaving, waxing and depilatory creams manage appearance but do not change follicle behaviour.
On the medication side, this page stays deliberately at the level of category. There are prescription approaches that lower ovarian androgen production and others that reduce androgen signalling in skin, and the hirsutism guideline supports pharmacologic management as a component of care for most women with clinically significant hirsutism 1. Which approach suits a given person, whether it suits them at all, and how it is used are decisions for a licensed prescriber after a full evaluation. No article can make that call, and nobody should start, stop or change anything based on one.
Expectations matter as much as the choice. Hair grows in cycles, so the effect of any approach on hair is judged over months rather than weeks, and the guideline reflects that in how response is assessed before changing course 1. Acne often responds on a different timeline from hair, which can be confusing when both are being addressed at once.
Scalp thinning in women is worked up as its own problem, because the pattern on the head does not always track with circulating androgen levels.
Female pattern hair loss typically presents as diffuse thinning over the mid scalp with a widening part and a preserved frontal hairline, and evaluation includes a scalp examination and targeted laboratory testing rather than androgen testing alone 3. Many women with this pattern do not have raised circulating androgens, which means a normal testosterone result does not rule the condition out 3.
Other contributors are common and often reversible, including iron deficiency, thyroid dysfunction and telogen effluvium following illness, significant weight loss or major stress. Sorting out which process is active, and whether more than one is, changes what helps.
For management, evidence suggests that topical and other recognised approaches to female pattern hair loss work best when started early and continued consistently, since the goal is maintaining existing follicles rather than recovering ones that have been dormant for years 3. Any prescription option is selected by a licensed provider after an evaluation of your scalp, your labs and your history.
If hair is the main reason you are reading this, that is worth saying plainly at your appointment, because the workup is broader than an androgen panel.
They can, particularly when insulin resistance is part of the picture, though the size of the effect varies a great deal between individuals.
Studies indicate that lifestyle measures, including dietary change and physical activity, are first-line components of care in polycystic ovary syndrome and may help improve both metabolic features and androgen-related features 2. Because insulin contributes to ovarian androgen output and suppresses SHBG, improving insulin sensitivity is one of the few levers that acts on the loop from more than one direction 4.
What this does not mean is that lifestyle alone resolves every case, or that a woman whose androgens stay raised has simply not tried hard enough. Phenotypes differ, and plenty of women with lean body composition have clear androgen excess 4.
A practical note on training. Hard resistance training builds strength and muscle through local adaptations, and it does not explain a persistently raised androgen result on repeat testing. If a value stays high across more than one properly timed draw, the explanation lies elsewhere and deserves a real evaluation rather than being attributed to the gym.
Sleep, stress and overall energy availability all influence how the hypothalamic, pituitary and ovarian axis behaves, so irregular cycles should be interpreted against those factors too rather than assumed to be hormonal in origin.
Any time the pattern is persistent, progressive or distressing, and immediately when onset is rapid or virilising features appear.
Specific prompts to book an appointment include coarse hair appearing in new areas, acne that keeps returning in adulthood, visible scalp thinning or a widening part, cycles that are consistently longer than about 35 days or fewer than roughly eight per year, periods that stop for several months, or a testosterone or DHEA-S result flagged outside the standard range. Features of virilisation, such as voice deepening, clitoral enlargement or rapid muscle bulk, are worth discussing with a clinician promptly 1.
When you go, bring the useful details. The date your symptoms started, how quickly they changed, your cycle pattern over the last year, any hormonal contraception or supplements you use, your family history, and copies of previous lab results with the dates and the laboratory named. That history often shortens the diagnostic path more than another round of testing would.
This article is educational and is not medical advice. Discuss your results and any treatment decision with a clinician or licensed provider who can evaluate your full history, and let that provider decide whether any option fits you.
If you want to go deeper, the Testosterone Total guide covers typical reference ranges and optimal targets for the marker itself. For scalp concerns, FitScript's explainer on how hair loss treatment for women works walks through evaluation and the categories of care, and the overview of hormone care for women describes how a licensed provider reviews hormone-related symptoms.
Laboratories regard a value above the upper end of the female reference range as elevated, but the number alone does not settle anything. Free testosterone and SHBG often matter more than the total, because only the unbound fraction acts on skin and hair follicles. A clinician reads the value alongside your symptoms, your cycle history and the other androgen markers before drawing any conclusion.
No. PCOS is the most common explanation, but adrenal causes and, rarely, an androgen-producing growth can raise the same marker. PCOS is also diagnosed by formal criteria that include cycle history and imaging, not by one blood value. Only a clinician who can see the full picture should make that call.
Both, plus SHBG. Total testosterone measures everything circulating, while free testosterone reflects what is actually available to your tissues, and SHBG explains the gap between the two. Ordering total on its own is the most common reason a woman is told her result is normal while her symptoms suggest otherwise.
Aim for an early morning draw in the first week of your cycle, roughly days 2 to 5 counting from the first day of bleeding. Androgens run higher in the morning, and 17-hydroxyprogesterone rises naturally after ovulation, so a mistimed sample can be misleading. If your cycles are absent or unpredictable, test on any convenient morning and tell your clinician, because the irregularity is itself useful information.
Usually not. Borderline values vary with timing, assay method and normal biological fluctuation, so repeating the test under proper conditions is common before anything changes. A markedly high value, or any result alongside rapidly progressing symptoms, is different and is worth discussing with a clinician promptly. Never ignore an abnormal result, but do not treat a single number as a diagnosis either.
DHEA-S comes almost entirely from the adrenal glands, so it helps locate the source of extra androgen. A DHEA-S that is disproportionately high compared with testosterone points attention toward the adrenal glands rather than the ovaries. That distinction changes which follow-up tests a clinician orders next.
Yes, and it is common. Hair follicles and oil glands convert testosterone locally into a more potent form, and follicle sensitivity varies between people, so visible features can appear while circulating values stay inside the standard range. Clinicians treat the visible pattern as real information in its own right rather than dismissing it because the labs read normal.
A licensed provider, after a full evaluation that includes your history, examination findings and labs. Options range from direct hair removal methods to prescription approaches, and suitability depends on your individual picture. Starting, stopping or changing any prescription option is a decision for that provider, not something to arrange on your own.